Stimcell Energetics (STME) Capital Expenditures (2016 - 2020)
Stimcell Energetics' (STME) quarterly Capital Expenditures came in at $1574.0 in Q3 2020, down 36.09% year-on-year from $2463.0 in Q3 2019, and down 36.09% quarter-over-quarter from $2463.0 in Q3 2019.
Stimcell Energetics (STME) Capital Expenditures (2016 - 2020) Analysis & Trends
Stimcell Energetics' Capital Expenditures history runs 5 years deep, the most recent figure standing at $1574.0 for Q3 2020.
- On a quarterly basis, Capital Expenditures fell 36.09% year-over-year to $1574.0 in Q3 2020; TTM through May 2021 was $1574.0, a 36.09% decrease from a year earlier, with the FY2021 full-year figure at $1574.0, down 36.09% from the prior year.
- Capital Expenditures fell to $1574.0 in Q3 2020 per STME's latest filing, from $2463.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $185242.0 in Q2 2016 and bottomed at $1574.0 in Q3 2020.
- The 5-year median for Capital Expenditures is $8701.5 (2016), against an average of $50238.0.
- Biggest YoY gain for Capital Expenditures was 36.09% in 2020; the steepest drop was 36.09% in 2020.
- Year by year, Capital Expenditures stood at $14940.0 in 2016, then jumped by 537.84% to $95294.0 in 2017, then plunged by 97.99% to $1915.0 in 2018, then advanced by 28.62% to $2463.0 in 2019, then plunged by 36.09% to $1574.0 in 2020.
- Per Business Quant, the three latest STME Capital Expenditures figures stand at $1574.0 (Q3 2020), $2463.0 (Q3 2019), and $1915.0 (Q4 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 76.60 Mn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 178.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | -85.46 Mn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2020 | 1,574.00 |
| Aug 31, 2020 | 1,574.00 |
| Aug 31, 2019 | 2,463.00 |
| Aug 31, 2019 | 2,463.00 |
| Nov 30, 2018 | 1,915.00 |
| Nov 30, 2018 | 1,915.00 |
| Feb 28, 2017 | 95,294.00 |
| Feb 28, 2017 | 95,294.00 |
| Aug 31, 2016 | 14,940.00 |
| Aug 31, 2016 | 14,940.00 |
| May 31, 2016 | 185,242.00 |
| May 31, 2016 | 185,242.00 |